JAZZ PHARMACEUTICALS SOBRE LOS RIESGOS E INCERTIDUMBRES CON LURBINECTEDIN ( ZEPZELCA ) ... : PREVEMOS QUE LURBINECTEDIN ( ZEPZELCA ) COMPITA CON PRODUCTOS GENÉRICOS EN EL FUTURO .
Trabectedin (Yondelis) Pharma Mar S.A. 11 August 2008 Full submission For the treatment of patients with advanced soft tissue sarcoma (STS) after failure of anthracyclines and ifosfamide or who are unsuited to receive these agents .